Policy makers and health plans seek value-based management of specialty drugs. This study examines real-world factors that favor some approaches over others and their potential impact. Objectives: ...
Prior authorization has been a flashpoint for providers, and, while insurers have taken steps to ease these utilization management protocols, they still play a key role as the industry shifts to value ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Through the Medicare Advantage Value-Based Insurance Design (VBID) ...
Value-focused patient care is transforming medical practice. As rising healthcare costs in the United States challenge the widely used fee-for-service architecture, innovative, patient-centered care ...
As it crushes the finances of physician practices and hospitals, the COVID-19 pandemic is making the most compelling argument yet for a fundamental shift in how our healthcare is funded and ...
Precision Value Based Management owns the technology that grades and ranks physicians for payers, hospital systems, and ACOs, with over 21 million patients that are being tracked. “They know exactly ...
This is the third article in a series on value-based care and the 4 challenges health care organizations must overcome. Patient experiences and outcomes must be the heartbeat of health care delivery.
About the Author: Ian Chiang is a principal at Flare Capital Partners, a healthcare technology and services-focused VC firm. Prior to joining Flare, he was the SVP of product and innovation and a ...
Business students need only three well taught courses: How to Value a Business, How to Think About Market Prices, and How to Manage a Business.—Inspired by Warren E. Buffett 2 A great deal has been ...
This article is the latest in the Health Affairs Forefront featured topic, Accountable Care for Population Health, featuring analysis and discussion of how to understand, design, support, and measure ...
The American healthcare system is on the brink, with an aging populace, structural frailties laid bare by covid, and unchecked cost escalation. Will the answers come from private or public investors ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results